Home HOME General Physiology and Biophysics 2021 General Physiology and Biophysics Vol.40, No.5, p. 397–407, 2021

Journal info


Quarterly, 80 pp. per issue
Founded: 1982
ISSN  1338-4325 (online)

Published in English

Aims and Scope
Editorial Info
Abstracting and Indexing
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

General Physiology and Biophysics Vol.40, No.5, p. 397–407, 2021

Title: Anti-leukaemia effects of leonurine in vitro and in vivo
Author: Qiang Zhuang, Lina Ruan, Ting Jin, Xiangkuo Zheng, Zhenlin Jin
Abstract: The present study was conducted to explore the anti-acute myeloid leukaemia (AML) effects of leonurine. HL-60 and U-937 cells were used to assess the antileukaemia effect of leonurine in vitro, and HL-60 and U-937 xenograft nude mice were used to evaluate its antitumour effect in vivo. Leonurine inhibited the proliferation of HL-60 and U-937 cells in a time- and dose-dependent manner. Moreover, leonurine therapy prevented the growth of tumours in both xenograft animal models. Leonurine could induce apoptosis in HL-60 and U-937 cells. The cytotoxic effects of leonurine on HL-60 and U-937 cells were associated with an increased ratio of Bax/Bcl-2, activation of caspase-3, caspase-8 and caspase-9, and increased expression of cytochrome c in the cytoplasm. Leonurine inhibited activation of the PI3K/Akt pathway in HL-60 and U-937 cells by lowering the phosphorylation levels of PI3K and Akt. Our results indicate that leonurine is a potential anti-AML agent, and this activity may be associated with its repression of the phosphorylation of PI3K and Akt.
Keywords: Leonurine — Acute myeloid leukaemia — PI3K — Akt — HL-60 — U-937
Published online: 27-Sep-2021
Year: 2021, Volume: 40, Issue: 5 Page From: 397, Page To: 407
doi:10.4149/gpb_2021018


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.